Vidalista and the Gut: Tadalafil’s Gastrointestinal Footprint
Tadalafil, the active pharmaceutical ingredient in Vidalista, is a long-acting phosphodiesterase type 5 (PDE-5) inhibitor commonly used for the treatment of erectile dysfunction (ED) and benign prostatic hyperplasia (BPH). Its extended half-life, often exceeding 24 hours, allows for flexible dosing, both once daily and as needed, which has contributed to its widespread popularity. However, its […]